169 related articles for article (PubMed ID: 32643482)
1. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus.
Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N
J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
3. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
4. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
[TBL] [Abstract][Full Text] [Related]
6. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
7. Nevus depigmentosus treated by melanocyte-keratinocyte transplantation.
Mulekar SV; Al Issa A; Al Eisa A
J Cutan Aesthet Surg; 2011 Jan; 4(1):29-32. PubMed ID: 21572678
[TBL] [Abstract][Full Text] [Related]
8. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.
Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV
J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633
[TBL] [Abstract][Full Text] [Related]
9. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo.
Refat MA; Strassner JP; Frisoli ML; Rashighi M; Richmond J; Nada E; Saleh R; El-Hamd MA; Goldberg D; Mahmoud BH; Harris JE
J Invest Dermatol; 2023 Nov; 143(11):2275-2282.e6. PubMed ID: 37478900
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
12. Clinical differences between segmental nevus depigmentosus and segmental vitiligo.
Roh D; Shin K; Kim WI; Yang MY; Lee WK; Kim GW; Kim HS; Ko HC; Kim BS; Kim MB
J Dermatol; 2019 Sep; 46(9):777-781. PubMed ID: 31342527
[TBL] [Abstract][Full Text] [Related]
13. Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure.
Yousif J; Ceresnie MS; Hamzavi IH; Mohammad TF
Arch Dermatol Res; 2023 Dec; 316(1):10. PubMed ID: 38038734
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Infection After Noncultured Melanocyte Keratinocyte Transplantation for Vitiligo.
Altalhab S; Shalaby SS; Saadi DG; Ezzedine K; AlJasser MI
Dermatol Surg; 2022 Mar; 48(3):310-314. PubMed ID: 35125442
[TBL] [Abstract][Full Text] [Related]
15. Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study.
El Hawary M; Bassiouny DA; Esmat S; Sobhi R; Saleh MA; AbdelHalim D; Hegazy R; Gawdat H; Ragab N; Samir N; Sany I
Dermatol Ther; 2020 Nov; 33(6):e14199. PubMed ID: 32798282
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Autologous Melanocyte/Keratinocyte Transplantation in Patients with Refractory Stable Vitiligo.
Shahbazi A; Abedi Valugerdi M; Kazemi S; Samadi Kochaksaraei S; Naseh MH; Aghdami N; Sadeghi B
Dermatology; 2023; 239(6):919-925. PubMed ID: 37573775
[TBL] [Abstract][Full Text] [Related]
17. Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions.
Gauthier Y; Surleve-Bazeille JE
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):191-4. PubMed ID: 1552051
[TBL] [Abstract][Full Text] [Related]
18. Fractional versus full ablative CO
Jamal-Edine AM; El-Barbary RA; Moftah NH
J Cosmet Dermatol; 2022 Apr; 21(4):1506-1513. PubMed ID: 34213808
[TBL] [Abstract][Full Text] [Related]
19. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus.
Lai LG; Xu AE
Skin Res Technol; 2011 Nov; 17(4):404-10. PubMed ID: 21429011
[TBL] [Abstract][Full Text] [Related]
20. Studying the effect of adding growth factors to the autologous melanocyte keratinocyte suspension in segmental vitiligo.
Esmat S; Bassiouny D; Saleh MA; AbdelHalim D; Hegazy R; ElHawary M; Gawdat H; Gouda H; Khorshied M; Samir N
Dermatol Ther; 2020 May; 33(3):e13368. PubMed ID: 32243651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
